Latest News about CRSP
Recent news which mentions CRSP
Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units
January 16, 2024
From Benzinga
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
January 16, 2024
From Motley Fool
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
January 15, 2024
From Motley Fool
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
January 15, 2024
From Motley Fool
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
From Motley Fool
Tickers
CRSP
From Motley Fool
7 Healthcare Stocks Taking Medicine to the Next Level
January 14, 2024
From InvestorPlace
My 3 Highest-Conviction Growth Stocks to Buy in 2024
January 14, 2024
From Motley Fool
My 5 Top Growth Stocks to Buy Hand Over Fist for 2024
January 14, 2024
From Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
January 13, 2024
From Motley Fool
2 Red Flags for Bluebird Bio Stock
January 10, 2024
From Motley Fool
3 Cathie Wood Stocks to Start Off Your New Year Right
January 10, 2024
From Motley Fool
The Ultimate Growth Stock to Buy With $1,000 Right Now
January 08, 2024
From Motley Fool
From Motley Fool
2 Biotech Stocks With Huge Catalysts in 2024
January 05, 2024
From Motley Fool
Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors
January 04, 2024
From InvestorPlace
Here's Why 2024 Could Be a Big Year for CRISPR Therapeutics
January 04, 2024
From Motley Fool
From InvestorPlace
Better Risky Investment: Bluebird Bio vs. Shiba Inu
January 03, 2024
From Motley Fool
3 Biotech Stocks Set for Breakthroughs in 2024
January 02, 2024
From InvestorPlace
Here's How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
January 01, 2024
From Benzinga
3 No-Brainer Growth Stocks to Buy for Less Than $100
January 01, 2024
From Motley Fool
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024
December 31, 2023
From Motley Fool
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
December 31, 2023
From Motley Fool
2023 in Review: Nvidia, Interest Rates, Taylor Swift
December 30, 2023
From Motley Fool
3 Stocks That Could Be Monster Winners in 2024
December 30, 2023
From Motley Fool
From InvestorPlace
3 Top Stocks to Buy Hand Over Fist Before the End of 2023
December 25, 2023
From Motley Fool
3 Healthcare Technology Stocks to Improve Lives in 2024
December 25, 2023
From InvestorPlace
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
December 23, 2023
From Motley Fool